Cellular functions regulated by phosphorylation of EGFR on TYR845

International Journal of Molecular Sciences

Volumn 14, Issue 6, 2013, Pages 10761-10790

  Sato, Ken ichi ^a  

^a KYOTO SANGYO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cancer; Cell proliferation; EGF; Mitochondria; Phosphorylation; Signal transduction; Src

Indexed keywords

ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ANASTROZOLE; CELECOXIB; CETUXIMAB; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; ERLOTINIB; GEFITINIB; GEMCITABINE; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SULINDAC SULFONE; TAMOXIFEN; TUMOR MARKER; TYROSINE; PHOSPHOTYROSINE;

APOPTOSIS; CANCER CELL; CANCER THERAPY; CELL ACTIVATION; CELL ADHESION; CELL CYCLE REGULATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; GAMETE; HUMAN; MITOCHONDRION; NONHUMAN; ONCOGENE SRC; PANCREAS CANCER; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SPERM; TRANSACTIVATION; ANIMAL; CHEMISTRY; METABOLISM; NEOPLASM; PHOSPHORYLATION;

ANIMALS; HUMANS; NEOPLASMS; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84878172399     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140610761     Document Type: Review

References (194)

1. Hunter, T. Tyrosine phosphorylation: Thirty years and counting. Curr. Opin. Cell Biol. 2009, 21, 140-146.
2. Jove, R, Hanafusa, H. Cell transformation by the viral src oncogene. Annu. Rev. Cell Biol. 1987, 3, 31-56.
3. Abram, C.L, Courtneidge, S.A. Src family tyrosine kinases and growth factor signaling. Exp. Cell Res. 2000, 254, 1-13.
4. Parsons, S.J, Parsons, J.T. Src family kinases, key regulators of signal transduction. Oncogene 2004, 23, 7906-7909.
5. Thomas, S.M, Brugge, J.S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 1997, 13, 513-609.
6. Brown, M.T, Cooper, J.A. Regulation, substrates and functions of Src. Biochim. Biophys. Acta 1996, 1287, 121-149.
7. Downward, J, Yarden, Y, Mayes, E, Scrace, G, Totty, N, Stockwell, P, Ullrich, A, Schlessinger, J, Waterfield, M.D. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 1984, 307, 521-527.
8. Carpenter, G, Cohen, S. Epidermal growth factor. J. Biol. Chem. 1990, 265, 7709-7712.
9. Yamamoto, T, Hihara, H, Nishida, T, Kawai, S, Toyoshima, K. A new avian erythroblastosis virus, AEV-H, carries erbB gene responsible for the induction of both erythroblastosis and sarcomas. Cell 1983, 34, 225-232.
10. Hackel, P.O, Zwick, E, Prenzel, N, Ullrich, A. Epidermal growth factor receptors: Critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol. 1999, 11, 184-189.
11. Kypta, R.M, Goldberg, Y, Ulug, E.T, Courtneidge, S.A. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 1990, 62, 481-492.
12. Kremer, N.E, D'Arcangelo, G, Thomas, S.M, DeMarco, M, Brugge, J.S, Halegoua, S. Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions. J. Cell Biol. 1991, 115, 809-819.
13. Courtneidge, S.A, Dhand, R, Pilat, D, Twamley, G.M, Waterfield, M.D, Roussel, M.F. Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J. 1993, 12, 943-950.
14. Zhan, X, Plourde, C, Hu, X, Friesel, R, Maciag, T. Association of fibroblast growth factor receptor-1 with c-Src correlates with association between c-Src and cortactin. J. Biol. Chem. 1994, 269, 20221-20224.
15. Muthuswamy, S.K, Siegel, P.M, Dankort, D.L, Webster, M.A, Muller, W.J. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol. 1994, 14, 735-743.
16. Luttrell, D.K, Luttrell, L.M, Parsons, S.J. Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol. Cell. Biol. 1988, 8, 497-501.
17. Carpenter, G. The biochemistry and physiology of the receptor-kinase for epidermal growth factor. Mol. Cell. Endocrinol. 1983, 31, 1-19.
18. Rozakis-Adcock, M, Fernley, R, Wade, J, Pawson, T, Bowtell, D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 1993, 363, 83-85.
19. Sato, K, Sato, A, Aoto, M, Fukami, Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 1995, 215, 1078-1087.
20. Biscardi, J.S, Maa, M.C, Tice, D.A, Cox, M.E, Leu, T.H, Parsons, S.J. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 1999, 274, 8335-8343.
21. Tice, D.A, Biscardi, J.S, Nickles, A.L, Parsons, S.J. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 1999, 96, 1415-1420.
22. Downward, J, Parker, P, Waterfield, M.D. Autophosphorylation sites on the epidermal growth factor receptor. Nature 1984, 311, 483-485.
23. Gill, G.N, Bertics, P.J, Santon, J.B. Epidermal growth factor and its receptor. Mol. Cell. Endocrinol. 1987, 51, 169-186.
24. Gill, G.N, Santon, J.B, Bertics, P.J. Regulatory features of the epidermal growth factor receptor. J. Cell Physiol. Suppl. 1987, 5, 35-41.
25. Margolis, B.L, Lax, I, Kris, R, Dombalagian, M, Honegger, A.M, Howk, R, Givol, D, Ullrich, A, Schlessinger, J. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J. Biol. Chem. 1989, 264, 10667-10671.
26. Walton, G.M, Chen, W.S, Rosenfeld, M.G, Gill, G.N. Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J. Biol. Chem. 1990, 265, 1750-1754.
27. Stover, D.R, Becker, M, Liebetanz, J, Lydon, N.B. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 α. J. Biol. Chem. 1995, 270, 15591-15597.
28. Ravid, T, Sweeney, C, Gee, P, Carraway, K.L., III; Goldkorn, T. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J. Biol. Chem. 2002, 277, 31214-31219.
29. Wright, J.D, Reuter, C.W, Weber, M.J. Identification of sites on epidermal growth factor receptors which are phosphorylated by pp60src in vitro. Biochim. Biophys. Acta 1996, 1312, 85-93.
30. Hunter, T, Ling, N, Cooper, J.A. Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane. Nature 1984, 311, 480-483.
31. Heisermann, G.J, Gill, G.N. Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo. J. Biol. Chem. 1988, 263, 13152-13158.
32. Kuppuswamy, D, Dalton, M, Pike, L.J. Serine 1002 is a site of in vivo and in vitro phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 1993, 268, 19134-19142.
33. Fukami, Y, Tokmakov, A.A, Konaka, K, Sato, K. Peptide inhibitors of the mitogen-activated protein kinase pathway: A structure-mimetic peptide corresponding to the conserved inter-DFG-APE region in the kinase domain. Pharmacol. Ther. 1999, 82, 399-407.
34. Hanks, S.K, Quinn, A.M, Hunter, T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 1988, 241, 42-52.
35. Cola, C, Brunati, A.M, Borin, G, Ruzza, P, Calderan, A, de Castiglione, R, Pinna, L.A. Synthetic peptides reproducing the EGF-receptor segment homologous to the pp60v-src phosphoacceptor site. Phosphorylation by tyrosine protein kinases. Biochim. Biophys. Acta 1989, 1012, 191-195.
36. Gotoh, N, Tojo, A, Hino, M, Yazaki, Y, Shibuya, M. A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor. Biochem. Biophys. Res. Commun. 1992, 186, 768-774.
37. Wilson, L.K, Luttrell, D.K, Parsons, J.T, Parsons, S.J. pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src. Mol. Cell. Biol. 1989, 9, 1536-1544.
38. Wilson, L.K, Parsons, S.J. Enhanced EGF mitogenic response is associated with enhanced tyrosine phosphorylation of specific cellular proteins in fibroblasts overexpressing c-src. Oncogene 1990, 5, 1471-1480.
39. Wasilenko, W.J, Payne, D.M, Fitzgerald, D.L, Weber, M.J. Phosphorylation and activation of epidermal growth factor receptors in cells transformed by the src oncogene. Mol. Cell. Biol. 1991, 11, 309-321.
40. Sato, K, Sato, A, Aoto, M, Fukami, Y. Site-specific association of c-Src with epidermal growth factor receptor in A431 cells. Biochem. Biophys. Res. Commun. 1995, 210, 844-851.
41. Fukami, Y, Sato, K, Ikeda, K, Kamisango, K, Koizumi, K, Matsuno, T. Evidence for autoinhibitory regulation of the c-src gene product. A possible interaction between the src homology 2 domain and autophosphorylation site. J. Biol. Chem. 1993, 268, 1132-1140.
42. Maa, M.C, Leu, T.H, McCarley, D.J, Schatzman, R.C, Parsons, S.J. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: Implications for the etiology of multiple human cancers. Proc. Natl. Acad. Sci. USA 1995, 92, 6981-6985.
43. Belsches, A.P, Haskell, M.D, Parsons, S.J. Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front. Biosci. 1997, 2, d501-d518.
44. Biscardi, J.S, Belsches, A.P, Parsons, S.J. Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol. Carcinog. 1998, 21, 261-272.
45. Biscardi, J.S, Ishizawar, R.C, Silva, C.M, Parsons, S.J. Tyrosine kinase signalling in breast cancer: Epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res. 2000, 2, 203-210.
46. Ishizawar, R, Parsons, S.J. c-Src and cooperating partners in human cancer. Cancer Cell 2004, 6, 209-214.
47. Kloth, M.T, Laughlin, K.K, Biscardi, J.S, Boerner, J.L, Parsons, S.J, Silva, C.M. STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J. Biol. Chem. 2003, 278, 1671-1679.
48. Sato, K, Nagao, T, Kakumoto, M, Kimoto, M, Otsuki, T, Iwasaki, T, Tokmakov, A.A, Owada, K, Fukami, Y. Adaptor protein Shc is an isoform-specific direct activator of the tyrosine kinase c-Src. J. Biol. Chem. 2002, 277, 29568-29576.
49. Sato, K, Nagao, T, Iwasaki, T, Nishihira, Y, Fukami, Y. Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells. Genes Cells 2003, 8, 995-1003.
50. Boerner, J.L, Biscardi, J.S, Silva, C.M, Parsons, S.J. Transactivating agonists of the EGF receptor require Tyr 845 phosphorylation for induction of DNA synthesis. Mol. Carcinog. 2005, 44, 262-273.
51. Haskell, M.D, Slack, J.K, Parsons, J.T, Parsons, S.J. c-Src tyrosine phosphorylation of epidermal growth factor receptor, P190 RhoGAP, and focal adhesion kinase regulates diverse cellular processes. Chem. Rev. 2001, 101, 2425-2440.
52. Sato, K, Kimoto, M, Kakumoto, M, Horiuchi, D, Iwasaki, T, Tokmakov, A.A, Fukami, Y. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells. Genes Cells 2000, 5, 749-764.
53. Xi, G, Shen, X, Clemmons, D.R. p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation. J. Biol. Chem. 2010, 285, 6937-6951.
54. MacLeod, C.L, Luk, A, Castagnola, J, Cronin, M, Mendelsohn, J. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells. J. Cell. Physiol. 1986, 127, 175-182.
55. Gulli, L.F, Palmer, K.C, Chen, Y.Q, Reddy, K.B. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity. Cell Growth Differ. 1996, 7, 173-178.
56. Boerner, J.L, Demory, M.L, Silva, C, Parsons, S.J. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol. Cell. Biol. 2004, 24, 7059-7071.
57. Demory, M.L, Boerner, J.L, Davidson, R, Faust, W, Miyake, T, Lee, I, Hüttemann, M, Douglas, R, Haddad, G, Parsons, S.J. Epidermal growth factor receptor translocation to the mitochondria: Regulation and effect. J. Biol. Chem. 2009, 284, 36592-36604.
58. Arachiche, A, Augereau, O, Decossas, M, Pertuiset, C, Gontier, E, Letellier, T, Dachary-Prigent, J. Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences. J. Biol. Chem. 2008, 283, 24406-24411.
59. Hebert-Chatelain, E, Jose, C, Gutierrez Cortes, N, Dupuy, J.W, Rocher, C, Dachary-Prigent, J, Letellier, T. Preservation of NADH ubiquinone-oxidoreductase activity by Src kinase-mediated phosphorylation of NDUFB10. Biochim. Biophys. Acta 2012, 1817, 718-725.
60. Miyazaki, T, Neff, L, Tanaka, S, Horne, W.C, Baron, R. Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J. Cell Biol. 2003, 160, 709-718.
61. Itoh, S, Lemay, S, Osawa, M, Che, W, Duan, Y, Tompkins, A, Brookes, P.S, Sheu, S.S, Abe, J. Mitochondrial Dok-4 recruits Src kinase and regulates NF-kappaB activation in endothelial cells. J. Biol. Chem. 2005, 280, 26383-26396.
62. Salvi, M, Brunati, A.M, Bordin, L, la Rocca, N, Clari, G, Toninello, A. Characterization and location of Src-dependent tyrosine phosphorylation in rat brain mitochondria. Biochim. Biophys. Acta 2002, 1589, 181-195.
63. Tibaldi, E, Brunati, A.M, Massimino, M.L, Stringaro, A, Colone, M, Agostinelli, E, Arancia, G, Toninello, A. Src-Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation. J. Cell. Biochem. 2008, 104, 840-849.
64. Tibaldi, E, Venerando, A, Zonta, F, Bidoia, C, Magrin, E, Marin, O, Toninello, A, Bordin, L, Martini, V, Pagano, M.A, et al. Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: A novel mechanism underlying delivery of Src family kinases to mitochondria. Biochem. J. 2011, 439, 505-516.
65. Hebert-Chatelain E. Src kinases are important regulators of mitochondrial functions. Int. J. Biochem. Cell Biol. 2013, 45, 90-98.
66. Ogura, M, Yamaki, J, Homma, M.K, Homma, Y. Mitochondrial c-Src regulates cell survival through phosphorylation of respiratory chain components. Biochem. J. 2012, 447, 281-289.
67. Cvrljevic, A.N, Akhavan, D, Wu, M, Martinello, P, Furnari, F.B, Johnston, A.J, Guo, D, Pike, L, Cavenee, W.K, Scott, A.M, et al. Activation of Src induces mitochondrial localisation of de2-7EGFR (EGFRvIII) in glioma cells: Implications for glucose metabolism. J. Cell Sci. 2011, 124, 2938-2950.
68. Miyake, T, Parsons, S.J. Functional interactions between choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Oncogene 2012, 31, 1431-1441.
69. Kannangai, R, Sahin, F, Torbenson, M.S. EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Mod. Pathol. 2006, 19, 1456-1461.
70. Jung, O, Choi, Y.J, Kwak, T.K, Kang, M, Lee, M.S, Ryu, J, Kim, H.J, Lee, J.W. The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation. Biochim. Biophys. Acta 2013, 1833, 629-642.
71. Kim, M, Jung, J, Lee, K. Roles of ERK, PI3 kinase, and PLCγ pathways induced by overexpression of translationally controlled tumor protein in HeLa cells. Arch. Biochem. Biophys. 2009, 485, 82-87.
72. Jung, J, Kim, H.Y, Kim, M, Sohn, K, Kim, M, Lee, K. Translationally controlled tumor protein induces human breast epithelial cell transformation through the activation of Src. Oncogene 2011, 30, 2264-2274.
73. Vieira, A.V, Lamaze, C, Schmid, S.L. Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 1996, 274, 2086-2089.
74. Ware, M.F, Tice, D.A, Parsons, S.J, Lauffenburger, D.A. Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor. J. Biol. Chem. 1997, 272, 30185-30190.
75. Medts, T, de Diesbach, P, Cominelli, A, N'Kuli, F, Tyteca, D, Courtoy, P.J. Acute ligand-independent Src activation mimics low EGF-induced EGFR surface signalling and redistribution into recycling endosomes. Exp. Cell Res. 2010, 316, 3239-3253.
76. Hu, J, Jo, M, Cavenee, W.K, Furnari, F, VandenBerg, S.R, Gonias, S.L. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. Proc. Natl. Acad. Sci. USA 2011, 108, 15984-15989.
77. Huang, P.H, Miraldi, E.R, Xu, A.M, Kundukulam, V.A, Del Rosario, A.M, Flynn, R.A, Cavenee, W.K, Furnari, F.B, White, F.M. Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol. Biosyst. 2010, 6, 1227-1237.
78. Ishizawar, R.C, Miyake, T, Parsons, S.J. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 2007, 26, 3503-3510.
79. Gschwantler-Kaulich, D, Hudelist, G, Koestler, W.J, Czerwenka, K, Mueller, R, Helmy, S, Ruecklinger, E, Kubista, E, Singer, C.F. EGFR activity in HER-2 over-expressing metastatic breast cancer: Evidence for simultaneous phosphorylation of Her-2/neu and EGFR. Oncol. Rep. 2005, 14, 305-311.
80. Chen, Y.R, Fu, Y.N, Lin, C.H, Yang, S.T, Hu, S.F, Chen, Y.T, Tsai, S.F, Huang, S.F. Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 2006, 25, 1205-1215.
81. Koizumi, F, Shimoyama, T, Taguchi, F, Saijo, N, Nishio, K. Establishment of a human non-small cell lung cancer cell line resistant to gefitinib. Int. J. Cancer 2005, 116, 36-44.
82. Chung, B.M, Dimri, M, George, M, Reddi, A.L, Chen, G, Band, V, Band, H. The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene 2009, 28, 1821-1832.
83. Chun, P.Y, Feng, F.Y, Scheurer, A.M, Davis, M.A, Lawrence, T.S, Nyati, M.K. Synergistic effects of gemcitabine and gefitinib in the treatment of head and neck carcinoma. Cancer Res. 2006, 66, 981-988.
84. Endoh, H, Ishibashi, Y, Yamaki, E, Yoshida, T, Yajima, T, Kimura, H, Kosaka, T, Onozato, R, Tanaka, S, Mitsudomi, T, et al. Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation. Lung Cancer. 2009, 63, 241-246.
85. Fink-Retter, A, Gschwantler-Kaulich, D, Hudelist, G, Mueller, R, Kubista, E, Czerwenka, K, Singer, C.F. Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer. Oncol. Rep. 2007, 18, 299-304.
86. Sonnweber, B, Dlaska, M, Skvortsov, S, Dirnhofer, S, Schmid, T, Hilbe, W. High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC). J. Clin. Pathol. 2006, 59, 255-259.
87. Fu, Y.N, Yeh, C.L, Cheng, H.H, Yang, C.H, Tsai, S.F, Huang, S.F, Chen, Y.R. EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: Implications in targeting therapy. Oncogene 2008, 27, 957-965.
88. Mueller, K.L, Hunter, L.A, Ethier, S.P, Boerner, J.L. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res. 2008, 68, 3314-3322.
89. Yamamoto, N, Mammadova, G, Song, R.X, Fukami, Y, Sato, K. Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells. J. Cell Sci. 2006, 119, 4623-4633.
90. Kihira, S, Yoshida, J, Kawada, Y, Hitomi, Y, Asada, T, Hisatomi, R, Ohta, A, Iwasaki, T, Mahbub Hasan, A.K, Fukami, Y, et al. Membrane microdomain-associated uroplakin IIIa contributes to Src-dependent mechanisms of anti-apoptotic proliferation in human bladder carcinoma cells. Biol. Open 2012, 1, 1024-1034.
91. Reznik, T.E, Sang, Y, Ma, Y, Abounader, R, Rosen, E.M, Xia, S, Laterra, J. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Mol. Cancer Res. 2008, 6, 139-150.
92. Knowlden, J.M, Hutcheson, I.R, Barrow, D, Gee, J.M, Nicholson, R.I. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor. Endocrinology 2005, 146, 4609-4618.
93. Hall, E.H, Gurel, V, Dahlberg, A.E, McMichael, J, Brautigan, D.L. Inhibition of human breast cancer matrigel invasion by streptolysin O activation of the EGF receptor ErbB1. Cell Signal. 2011,23, 1972-1977.
94. Iwasaki, T, Mukai, M, Tsujimura, T, Tatsuta, M, Nakamura, H, Terada, N, Akedo, H. Ipriflavone inhibits osteolytic bone metastasis of human breast cancer cells in a nude mouse model. Int. J. Cancer 2002, 100, 381-387.
95. Aquino, G, Pannone, G, Santoro, A, Liguori, G, Franco, R, Serpico, R, Florio, G, de Rosa, A, Mattoni, M, Cozza, V, et al. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: A tissue-microarray study with clinic-pathological correlations. Cancer Biol. Ther.2012, 13, 967-977.
96. Dhupkar, P, Dowling, M, Cengel, K, Chen, B. Effects of anti-EGFR antibody cetuximab on androgen-independent prostate cancer cells. Anticancer Res. 2010, 30, 1905-1910.
97. Jones, H.E, Gee, J.M, Barrow, D, Tonge, D, Holloway, B, Nicholson, R.I. Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. Br. J. Cancer 2006, 95, 172-180.
98. Polychronis, A, Sinnett, H.D, Hadjiminas, D, Singhal, H, Mansi, J.L, Shivapatham, D, Shousha, S, Jiang, J, Peston, D, Barrett, N, et al. Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: A double-blind placebo-controlled phase II randomised trial. Lancet Oncol. 2005, 6, 383-391.
99. Kandala, P.K, Wright, S.E, Srivastava, S.K. Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo. J. Pharmacol. Exp. Ther. 2012, 341, 24-32.
100. Kong, L, Deng, Z, Shen, H, Zhang, Y. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Mol. Cell Biochem. 2011, 348, 11-19.
101. Li, Z, Hosoi, Y, Cai, K, Tanno, Y, Matsumoto, Y, Enomoto, A, Morita, A, Nakagawa, K, Miyagawa, K. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation. Biochem. Biophys. Res. Commun. 2006, 341, 363-368.
102. Maruko, A, Ohtake, Y, Kawaguchi, M, Kobayashi, T, Baba, T, Kuwahara, Y, Nakagawa, H, Shimura, T, Fukumoto, M, Ohkubo, Y. X-radiation-induced down-regulation of the EGF receptor in primary cultured rat hepatocytes. Radiat. Res. 2010, 173, 620-628.
103. Lu, Y, Li, X, Liang, K, Luwor, R, Siddik, Z.H, Mills, G.B, Mendelsohn, J, Fan, Z. Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab. Cancer Res. 2007, 67, 8240-8247.
104. Li, X, Lu, Y, Liang, K, Hsu, J.M, Albarracin, C, Mills, G.B, Hung, M.C, Fan, Z. Brk/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR. Oncogene 2012, 31, 4372-4383.
105. Morgan, M.A, Parsels, L.A, Kollar, L.E, Normolle, DP, Maybaum, J, Lawrence, T.S. The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer. Clin. Cancer Res. 2008, 14, 5142-5149.
106. Selvendiran, K, Bratasz, A, Tong, L, Ignarro, L.J, Kuppusamy, P. NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. Cell Cycle 2008, 7, 81-88.
107. Narayanan, B.A, Reddy, B.S, Bosland, M.C; Nargi, D, Horton, L, Randolph, C, Narayanan, N.K. Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: In vivo evidence. Clin. Cancer Res. 2007, 13, 5965-5973.
108. Hudelist, G; Köstler, W.J, Czerwenka, K, Kubista, E, Attems, J, Müller, R, Gschwantler-Kaulich, D, Manavi, M, Huber, I, Hoschützky, H, et al. Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer. Int. J. Cancer 2006, 118, 1126-1134.
109. Thelemann, A, Petti, F, Griffin, G, Iwata, K, Hunt, T, Settinari, T, Fenyo, D, Gibson, N, Haley, J.D. Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol. Cell Proteomics 2005, 4, 356-376.
110. Fischgräbe, J, Götte, M, Michels, K, Kiesel, L, Wülfing, P. Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells. Int. J. Cancer 2010, 127, 696-706.
111. Park, Y.J, Lee, H, Lee, J.H. Macrophage inhibitory cytokine-1 transactivates ErbB family receptors via the activation of Src in SK-BR-3 human breast cancer cells. BMB Rep. 2010, 43, 91-96.
112. Drube, S, Stirnweiss, J, Valkova, C; Liebmann, C. Ligand-independent and EGF receptor-supported transactivation: Lessons from p2-adrenergic receptor signalling. Cell Signal. 2006, 18, 1633-1646.
113. Du, T, Li, B, Li, H, Li, M, Hertz, L, Peng, L. Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent. J. Neurochem. 2010, 115, 1007-1023.
114. Du, T, Li, B, Liu, S, Zang, P, Prevot, V, Hertz, L, Peng, L. ERK phosphorylation in intact, adult brain by adrenergic transactivation of EGF receptors. Neurochem. Int. 2009, 55, 593-600.
115. Amos, S, Martin, P.M, Polar, G.A, Parsons, S.J, Hussaini, I.M. Phorbol 12-myristate 13-acetate induces epidermal growth factor receptor transactivation via protein kinase C6/c-Src pathways in glioblastoma cells. J. Biol. Chem. 2005, 280, 7729-7738.
116. Lin, C.R, Chen, W.S, Lazar, C.S, Carpenter, CD, Gill, G.N, Evans, R.M, Rosenfeld, M.G Protein kinase C phosphorylation at Thr 654 of the unoccupied EGF receptor and EGF binding regulate functional receptor loss by independent mechanisms. Cell 1986, 44, 839-848.
117. Van Baal, J, de Widt, J, Divecha, N, van Blitterswijk, W.J. Diacylglycerol kinase 0 counteracts protein kinase C-mediated inactivation of the EGF receptor. Int. J. Biochem. Cell Biol. 2012, 44, 1791-1799.
118. Reinehr, R, Sommerfeld, A, Häussinger, D. Insulin induces swelling-dependent activation of the epidermal growth factor receptor in rat liver. J. Biol. Chem. 2010, 285, 25904-25912.
119. Chen, J, Chen, J.K, Harris, R.C. Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway. Mol. Cell Biol 2012, 32, 981-991.
120. Kim, J, Ahn, S, Rajagopal, K, Lefkowitz, R.J. Independent P-arrestin2 and Gq/protein kinase CC pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J. Biol. Chem. 2009, 284, 11953-11962.
121. Nair, V.D, Sealfon, S.C. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J. Biol. Chem. 2003, 278, 47053-47061.
122. Santiskulvong, C, Rozengurt, E. Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. Exp. Cell Res. 2003, 290, 437-446.
123. Dittmann, K, Mayer, C, Kehlbach, R, Rodemann, H.P. Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK. Mol. Cancer. 2008, 7, 69.
124. Dittmann, K, Mayer, C, Kehlbach, R, Rodemann, H.P. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Radiother. Oncol. 2008, 86, 375-382.
125. Iordanov, M.S, Choi, R.J, Ryabinina, O.P, Dinh, T.H, Bright, R.K, Magun, B.E. The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor. Mol. Cell. Biol. 2002, 22, 5380-5394.
126. Gardner, O.S, Dewar, B.J, Earp, H.S, Samet, J.M, Graves, L.M. Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation. J. Biol. Chem. 2003, 278, 46261-46269.
127. Mueller, K.L, Powell, K, Madden, J.M, Eblen, S.T, Boerner, J.L. EGFR tyrosine 845 phosphorylation-dependent proliferation and transformation of breast cancer cells require activation of p38 MAPK. Transl. Oncol. 2012, 5, 327-334.
128. Samarakoon, R, Higgins, C.E, Higgins, S.P, Higgins, P.J. Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption. Cell. Signal. 2009, 21, 986-995.
129. Jo, M, Thomas, K.S, Marozkina, N, Amin, T.J, Silva, C.M, Parsons, S.J, Gonias, S.L. Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J. Biol. Chem. 2005, 280, 17449-17457.
130. Jo, M, Thomas, K.S, Takimoto, S, Gaultier, A, Hsieh, E.H, Lester, R.D, Gonias, S.L. Urokinase receptor primes cells to proliferate in response to epidermal growth factor. Oncogene 2007, 26, 2585-2594.
131. Monaghan-Benson, E, McKeown-Longo, P.J. Urokinase-type plasminogen activator receptor regulates a novel pathway of fibronectin matrix assembly requiring Src-dependent transactivation of epidermal growth factor receptor. J. Biol. Chem. 2006, 281, 9450-9459.
132. Goldshmit, Y, Walters, C.E, Scott, H.J, Greenhalgh, C.J, Turnley, A.M. SOCS2 induces neurite outgrowth by regulation of epidermal growth factor receptor activation. J. Biol. Chem. 2004, 279, 16349-16355.
133. Tseng, H.Y, Liu, Z.M, Huang, H.S. NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes. Arch. Toxicol. 2012, 86, 935-945.
134. Rodríguez-Fragoso, L, Melendez, K, Hudson, L.G, Lauer, F.T, Burchiel, S.W. EGF-receptor phosphorylation and downstream signaling are activated by benzo[a]pyrene 3,6-quinone and benzo[a]pyrene 1,6-quinone in human mammary epithelial cells. Toxicol. Appl. Pharmacol. 2009, 235, 321-328.
135. Martínez Flores, K, Uribe Marín, B, Souza Arroyo, V, Bucio Ortiz, L, López Reyes, A, Gómez-Quiroz, L.E, Rojas del Castillo, E, Gutiérrezruiz, M. Hepatocytes display a compensatory survival response against cadmium toxicity by a mechanism mediated by EGFR and Src. Toxicol. In Vitro 2013, in press.
136. Godek, J, Sargiannidou, I, Patel, S, Hurd, L, Rothman, V.L, Tuszynski, G.P. Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-κB). Exp. Mol. Pathol. 2011, 90, 244-251.
137. Liu, A, Garg, P, Yang, S, Gong, P, Pallero, M.A, Annis, D.S, Liu, Y, Passaniti, A, Mann, D, Mosher, D.F, et al. Epidermal growth factor-like repeats of thrombospondins activate phospholipase Cγ and increase epithelial cell migration through indirect epidermal growth factor receptor activation. J. Biol. Chem. 2009, 284, 6389-6402.
138. Westover, E.J, Covey, D.F, Brockman, H.L, Brown, R.E, Pike, L.J. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J. Biol. Chem. 2003, 278, 51125-51133.
139. Brown, D.A, London, E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 1998, 14, 111-136.
140. Anderson, R.G. The caveolae membrane system. Annu. Rev. Biochem. 1998, 67, 199-225.
141. Mahbub Hasan, A.K, Fukami, Y, Sato, K. Gamete membrane microdomains and their associated molecules in fertilization signaling. Mol. Reprod. Dev. 2011, 78, 814-830.
142. Mahbub Hasan, A.K, Ijiri, T, Sato, K. Involvement of Src in the adaptation of cancer cells under microenvironmental stresses. J. Signal Transduct. 2012, 2012, doi:10.1155/2012/483796.
143. Simons, K, Ikonen, E. Functional rafts in cell membranes. Nature 1997, 387, 569-572.
144. Liu, Y.T, Song, L, Templeton, D.M. Heparin suppresses lipid raft-mediated signaling and ligand-independent EGF receptor activation. J. Cell. Physiol. 2007, 211, 205-212.
145. Higgins, S.P, Samarakoon, R, Higgins, C.E, Freytag, J, Wilkins-Port, C.E, Higgins, P.J. TGF-β1-induced expression of the anti-apoptotic PAI-1 protein requires EGFR signaling. Cell Commun. Insights 2009, 2, 1-11.
146. Samarakoon, R, Higgins, S.P, Higgins, C.E, Higgins, P.J. TGF-β1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60c-src/EGFR(Y845) and Rho/ROCK signaling. J. Mol. Cell Cardiol. 2008, 44, 527-538.
147. Kim, J.H, Xu, C, Keum, Y.S, Reddy, B, Conney, A, Kong, A.N. Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with β-phenylethyl isothiocyanate and curcumin. Carcinogenesis 2006, 27, 475-482.
148. Amorino, G.P, Deeble, P.D, Parsons, S.J. Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Oncogene 2007, 26, 745-756.
149. Ray, R.M, Bhattacharya, S., Johnson, L.R. EGFR plays a pivotal role in the regulation of polyamine-dependent apoptosis in intestinal epithelial cells. Cell. Signal. 2007, 19, 2519-2527.
150. Reinehr, R, Becker, S, Wettstein, M, Häussinger D. Involvement of the Src family kinase yes in bile salt-induced apoptosis. Gastroenterology 2004, 127, 1540-1557.
151. Reinehr, R, Becker, S, Eberle, A, Grether-Beck, S, Häussinger, D. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 2005, 280, 27179-27194.
152. Wang, Z, Wang, M, Carr, B.I. Integrin α5-induced EGFR activation by prothrombin triggers hepatocyte apoptosis via the JNK signaling pathway. J. Cell. Physiol. 2008, 216, 551-557.
153. Moro, L, Dolce, L, Cabodi, S, Bergatto, E, Boeri Erba, E, Smeriglio, M, Turco, E, Retta, S.F, Giuffrida, M.G, Venturino, M, et al. Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines. J. Biol. Chem. 2002, 277, 9405-9414.
154. Wang, X.Q, Sun, P, Paller, A.S. Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J. Biol. Chem. 2003, 278, 48770-48778.
155. Balanis, N, Yoshigi, M, Wendt, M.K, Schiemann, W.P, Carlin, C.R. β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. Mol. Biol. Cell. 2011, 22, 4288-4301.
156. Balanis, N, Carlin, C.R. Mutual cross-talk between fibronectin integrins and the EGF receptor: Molecular basis and biological significance. Cell Logist. 2012, 2, 46-51.
157. Perrais, M, Chen, X, Perez-Moreno, M, Gumbiner, B.M. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol. Biol. Cell 2007, 18, 2013-2025.
158. Riggins, R.B, Thomas, K.S, Ta, H.Q, Wen, J, Davis, R.J, Schuh, N.R, Donelan, S.S, Owen, K.A, Gibson, M.A, Shupnik, M.A, et al. Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res. 2006, 66, 7007-7015.
159. Pan, Q, Qiu, W.Y, Huo, Y.N, Yao, Y.F, Lou, M.F. Low levels of hydrogen peroxide stimulate corneal epithelial cell adhesion, migration, and wound healing. Invest. Ophthalmol. Vis. Sci. 2011, 52, 1723-1734.
160. Daniel, L, Etkovitz, N, Weiss, S.R, Rubinstein, S, Ickowicz, D, Breitbart, H. Regulation of the sperm EGF receptor by ouabain leads to initiation of the acrosome reaction. Dev. Biol. 2010, 344, 650-657.
161. Luna, C, Colás, C, Pérez-Pé, R, Cebrián-Pérez, J.A, Muiño-Blanco, T. A novel epidermal growth factor-dependent extracellular signal-regulated MAP kinase cascade involved in sperm functionality in sheep. Biol. Reprod. 2012, 87, 93.
162. Fassett, J, Tobolt, D, Hansen, L.K. Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A. Mol. Biol. Cell 2006, 17, 345-356.
163. Luo, L, Yano, N, Luo, J.Z. The molecular mechanism of EGF receptor activation in pancreatic β-cells by thyrotropin-releasing hormone. Am. J Physiol. Endocrinol. MeTable 2006, 290, E889-E899.
164. McEneaney, V, Harvey, B.J, Thomas, W. Aldosterone rapidly activates protein kinase D via a mineralocorticoid receptor/EGFR trans-activation pathway in the M1 kidney CCD cell line. J. Steroid Biochem. Mol. Biol. 2007, 107, 180-190.
165. Wu, W, Graves, L.M, Gill, G.N, Parsons, S.J, Samet, J.M. Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation. J. Biol. Chem. 2002, 277, 24252-24257.
166. Samet, J.M, Dewar, B.J, Wu, W, Graves, L.M. Mechanisms of Zn2+-induced signal initiation through the epidermal growth factor receptor. Toxicol. Appl. Pharmacol. 2003, 191, 86-93.
167. Pontillo, C.A, García, M.A, Peña, D, Cocca, C, Chiappini, F, Alvarez, L, Kleiman de Pisarev, D, Randi, A.S. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line. Toxicol. Sci. 2011, 120, 284-296.
168. Randi, A.S, Sanchez, M.S, Alvarez, L, Cardozo, J, Pontillo, C, Kleiman de Pisarev, D.L. Hexachlorobenzene triggers AhR translocation to the nucleus, c-Src activation and EGFR transactivation in rat liver. Toxicol. Lett. 2008, 177, 116-122.
169. Churg, A, Xie, C, Wang, X, Vincent, R, Wang, R.D. Air pollution particles activate NF-κB on contact with airway epithelial cell surfaces. Toxicol. Appl. Pharmacol. 2005, 208, 37-45.
170. Xu, K.P, Yin, J, Yu, F.S. SRC-family tyrosine kinases in wound- and ligand-induced epidermal growth factor receptor activation in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 2006, 47, 2832-2839.
171. Peng, Z, Raufman, J.P, Xie, G. Src-mediated cross-talk between farnesoid X and epidermal growth factor receptors inhibits human intestinal cell proliferation and tumorigenesis. PLoS One 2012, 7, e48461.
172. Xie, G, Peng, Z, Raufman, J.P. Src-mediated aryl hydrocarbon and epidermal growth factor receptor cross talk stimulates colon cancer cell proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 302, G1006-G1015.
173. Allahverdian, S, Wang, A, Singhera, G.K, Wong, B.W, Dorscheid, D.R. Sialyl Lewis X modification of the epidermal growth factor receptor regulates receptor function during airway epithelial wound repair. Clin. Exp. Allergy. 2010, 40, 607-618.
174. Hyun, S.W, Anglin, I.E, Liu, A, Yang, S, Sorkin, J.D, Lillehoj, E, Tonks, N.K, Passaniti, A, Goldblum, S.E. Diverse injurious stimuli reduce protein tyrosine phosphatase-μ expression and enhance epidermal growth factor receptor signaling in human airway epithelia. Exp. Lung Res. 2011, 37, 327-343.
175. Matus, C.E, Ehrenfeld, P, Pavicic, F, Sarmiento, J.M, Astroza, A, Sanchez, T, Salem, C, Concha, M, Vidal, M.A, Gonzalez, C.B, et al. Activation of kinin B receptor triggers differentiation of cultured human keratinocytes. Br. J. Dermatol. 2008, 159, 792-803.
176. Kansra, S, Stoll, S.W, Johnson, J.L, Elder, J.T. Src family kinase inhibitors block amphiregulin-mediated autocrine ErbB signaling in normal human keratinocytes. Mol. Pharmacol. 2005, 67, 1145-1157.
177. Hur, E.M, Park, Y.S, Lee, B.D, Jang, I.H, Kim, H.S, Kim, T.D, Suh, P.G, Ryu, S.H, Kim, K.T. Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains. J. Biol. Chem. 2004, 279, 5852-5860.
178. Gao, Z, Yang, J, Huang, Y, Yu, Y. N-methyl-N'-nitro-N-nitrosoguanidine interferes with the epidermal growth factor receptor-mediated signaling pathway. Mutat. Res. 2005, 570, 175-184.
179. Iida, M, Brand, T.M, Campbell, D.A, Li, C, Wheeler, D.L. Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor. Oncogene 2012, 32, 759-767.
180. De Bondt, H.L, Rosenblatt, J, Jancark, J, Jones, H.D, Morgan, D.O, Kim, S.-U. Crystal structure of cyclin-dependent kinase 2. Nature 1993, 363, 595-602.
181. Jeffrey, P.D, Russo, A.A, Polyak, K, Gibbs, E, Hurwitz, J, Massague, J, Pavletich, N.P. Mechanism of CDK activation revealed by the structure of a cylin A-CDK2 complex. Nature 1995, 376, 313-320.
182. Johnson, L.N, Noble, M.E, Owen, D.J. Active and inactive protein kinases: Structural basis for regulation. Cell 1996, 85, 149-158.
183. Sicheri, F, Moarefi, I, Kuriyan, J. Crystal structure of the Src family kinase Hck. Nature 1997, 385, 602-609.
184. Taylor, S.S, Yang, J, Wu, J, Haste, N.M, Radzio-Andzelm, E, Anand, G. PKA: A portrait of protein kinase dynamics. Biochim. Biophys. Acta 2004, 1697, 259-269.
185. Xu, W, Harrison, S, Eck, M.J. Three-dimensional structure of the tyrosine kinase c-Src. Nature 1997, 835, 595-602.
186. Zhang, F, Strand, A, Robbins, D, Cobb, M.H, Goldsmith, E.J. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution. Nature 1994, 367, 704-711.
187. Choi, S.H, Mendrola, J.M, Lemmon, M.A. EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer. Oncogene 2007, 26, 1567-1576.
188. Yang, S, Park, K, Turkson, J, Arteaga, C.L. Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression. Exp. Cell Res. 2008, 314, 413-419.
189. Shan, Y, Eastwood, M.P, Zhang, X, Kim, E.T, Arkhipov, A, Dror, R.O, Jumper, J, Kuriyan, J, Shaw, D.E. Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization. Cell 2012, 149, 860-870.
190. Timms, J.F, Noble, M.E, Gregoriou, M. An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor. Biochem. J. 1995, 308, 219-229.
191. Poppleton, H.M, Wiepz, G.J, Bertics, P.J, Patel, T.B. Modulation of the protein tyrosine kinase activity and autophosphorylation of the epidermal growth factor receptor by its juxtamembrane region. Arch. Biochem. Biophys. 1999, 363, 227-236.
192. Qiu, C, Tarrant, M.K, Boronina, T, Longo, P.A, Kavran, J.M, Cole, R.N, Cole, P.A, Leahy, D.J. In vitro enzymatic characterization of near full length EGFR in activated and inhibited states. Biochemistry 2009, 48, 6624-6632.
193. Buerger, C, Nagel-Wolfrum, K, Kunz, C, Wittig, I, Butz, K, Hoppe-Seyler, F, Groner, B. Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells. J. Biol. Chem. 2003, 278, 37610-37621.
194. Kim, S.K, Huang, L. Nanoparticle delivery of a peptide targeting EGFR signaling. J. Control. Release 2012, 157, 279-286.